Rentschler Biopharma SE — located in Laupheim, Germany — is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company’s clients include innovative biotech companies and major pharmaceutical companies around the world. Rentschler Biopharma has long-standing experience and proven excellence as a solution partner of choice. A top-notch quality management system, well-established operational excellence, and advanced technologies ensure product quality at each development and manufacturing step. Rentschler Biopharma is a family-owned company with over 850 employees.
One-Stop Solutions from Gene to Vial and Clinic to Market: Rentschler Biopharma’s end-to-end offering includes biopharmaceutical process development and manufacturing as well as related consulting activities, including project management and regulatory support. With a focus on mammalian cell lines, Rentschler Biopharma is highly experienced in the development and CGMP manufacturing of monoclonal antibodies, fusion proteins, and other therapeutic proteins in compliance with international standards (EMA/FDA).
Just fill out this form to download a PDF and learn more.